Well Lead Medical Co., Ltd. (603309.SS)
CNY 11.52
(2.31%)
CNY 11.52
(2.31%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 93.7 Million CNY | 170.44% |
| 2022 | -133.02 Million CNY | 63.45% |
| 2021 | -363.91 Million CNY | -1214.71% |
| 2020 | -27.68 Million CNY | -152.5% |
| 2019 | 52.72 Million CNY | -51.38% |
| 2018 | 108.43 Million CNY | 180.57% |
| 2017 | -134.58 Million CNY | -20.79% |
| 2016 | -111.42 Million CNY | -13.68% |
| 2015 | -98.01 Million CNY | -100.42% |
| 2014 | -48.9 Million CNY | -576.23% |
| 2013 | -7.23 Million CNY | -143.58% |
| 2012 | 16.59 Million CNY | -52.63% |
| 2011 | 35.03 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q3 | 257.53 Million CNY | -25.62% |
| 2024 Q1 | 189.62 Million CNY | 102.36% |
| 2024 Q2 | 387.51 Million CNY | 104.36% |
| 2023 Q1 | -12.53 Million CNY | 90.58% |
| 2023 Q4 | 93.7 Million CNY | 192.67% |
| 2023 FY | 93.7 Million CNY | 170.44% |
| 2023 Q3 | 32.01 Million CNY | 56.95% |
| 2023 Q2 | 20.4 Million CNY | 262.76% |
| 2022 Q1 | -35.3 Million CNY | 90.3% |
| 2022 FY | -133.02 Million CNY | 63.45% |
| 2022 Q4 | -133.02 Million CNY | -1523.66% |
| 2022 Q3 | 9.34 Million CNY | -89.44% |
| 2022 Q2 | 88.46 Million CNY | 350.54% |
| 2021 Q4 | -363.91 Million CNY | -478.63% |
| 2021 Q2 | 67.61 Million CNY | -8.71% |
| 2021 FY | -363.91 Million CNY | -1214.71% |
| 2021 Q3 | 96.11 Million CNY | 42.15% |
| 2021 Q1 | 74.07 Million CNY | 367.59% |
| 2020 Q4 | -27.68 Million CNY | -553.99% |
| 2020 Q3 | 6.09 Million CNY | -85.0% |
| 2020 Q2 | 40.64 Million CNY | -21.76% |
| 2020 FY | -27.68 Million CNY | -152.5% |
| 2020 Q1 | 51.94 Million CNY | -1.47% |
| 2019 Q2 | 146.59 Million CNY | 33.98% |
| 2019 Q1 | 109.41 Million CNY | 0.9% |
| 2019 FY | 52.72 Million CNY | -51.38% |
| 2019 Q4 | 52.72 Million CNY | -58.77% |
| 2019 Q3 | 127.86 Million CNY | -12.78% |
| 2018 Q3 | -47.9 Million CNY | 47.71% |
| 2018 Q4 | 108.43 Million CNY | 326.35% |
| 2018 FY | 108.43 Million CNY | 180.57% |
| 2018 Q1 | -97.21 Million CNY | 27.77% |
| 2018 Q2 | -91.62 Million CNY | 5.75% |
| 2017 Q2 | -161.05 Million CNY | -34.94% |
| 2017 FY | -134.58 Million CNY | -20.79% |
| 2017 Q4 | -134.58 Million CNY | 23.0% |
| 2017 Q3 | -174.79 Million CNY | -8.53% |
| 2017 Q1 | -119.35 Million CNY | -7.12% |
| 2016 Q3 | -94.89 Million CNY | 32.55% |
| 2016 FY | -111.42 Million CNY | -13.68% |
| 2016 Q4 | -111.42 Million CNY | -17.42% |
| 2016 Q2 | -140.69 Million CNY | 34.1% |
| 2016 Q1 | -213.5 Million CNY | -117.82% |
| 2015 Q3 | -90.27 Million CNY | 41.02% |
| 2015 FY | -98.01 Million CNY | -100.42% |
| 2015 Q4 | -98.01 Million CNY | -8.58% |
| 2015 Q2 | -153.04 Million CNY | -47.5% |
| 2015 Q1 | -103.75 Million CNY | -112.16% |
| 2014 Q2 | -16.47 Million CNY | -122.73% |
| 2014 Q4 | -48.9 Million CNY | 0.0% |
| 2014 Q1 | 72.48 Million CNY | 0.0% |
| 2014 FY | -48.9 Million CNY | -576.23% |
| 2013 FY | -7.23 Million CNY | -143.58% |
| 2012 FY | 16.59 Million CNY | -52.63% |
| 2011 FY | 35.03 Million CNY | 0.0% |